|
|
|
| Research progress on the role of candida mycoderma bacteria in female vaginal microecosystem |
| ZONG Xiaonan1 WANG Fengjuan2 LIU Zhaohui1 |
1.Department of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University Beijing Maternal and Child Health Care Hospital, Beijing 100026, China;
2.Department of Obstetrics, Beijing Obstetrics and Gynecology Hospital, Capital Medical University Beijing Maternal and Child Health Care Hospital, Beijing 100026, China
|
|
|
|
Abstract Candida mycoderma bacteria is an opportunistic pathogen, which is one of the main causes of vulvovaginitis. With the wide use of genomics tools, the important and complex role of vaginal fungal community in human health and disease are increasingly recognized. Exploring the fungal species, functions and interactions with different microbial species in vaginal microecosystem is very important for the treatment and prevention of vaginitis and cervical diseases, and the improvement of pregnancy outcomes and reproductive health. This paper reviews the role of candida mycoderma bacteria in female health and disease.
|
|
|
|
|
|
[1] Ahrodia T，Das S，Bakshi S，et al. Structure，functions，and diversity of the healthy human microbiome [J]. Prog Mol Biol Transl Sci，2022，191（1）：53-82.
[2] Proctor L. Priorities for the next 10 years of human microbiome research [J]. Nature，2019，569（7758）：623-625.
[3] Shiao SL，Kershaw KM，Limon JJ，et al. Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy [J]. Cancer Cell，2021，39（9）：1202-1213.
[4] Begum N，Harzandi A，Lee S，et al. Host-mycobiome metabolic interactions in health and disease [J]. Gut Microbes，2022， 14（1）：2121576.
[5] Voth E，Khanna S. The Integrative Human microbiome project：a mile stone in the understanding of the gut microbiome [J]. Expert Rev Gastroenterol Hepatol，2020，14（8）：639-642.
[6] Sun Y，Zuo T，Cheung CP，et al. Population-Level Configurations of Gut Mycobiome Across 6 Ethnicities in Urban and Rural China [J]. Gastroenterology，2021，160（1）：272-286.
[7] Tiew PY，Mac Aogain M，Ali NABM，et al. The Mycobiome in Health and Disease：Emerging Concepts，Methodologies and Challenges [J]. Mycopathologia，2020，185（2）：207-231.
[8] Wilck N. What’s for dinner? Why a close look at diet and microbiota is worthwhile in experimental hypertension research [J]. Acta Physiol （Oxf），2021，232（4）：e13704.
[9] The Integrative Human Microbiome Project[J]. Nature，2019， 569（7758）：641-648.
[10] Case NT，Berman J，Blehert DS，et al. The future of fungi：threats and opportunities [J]. G3 （Bethesda），2022，12（11）：jkac224.
[11] Santus W，Devlin JR，Behnsen J. Crossing Kingdoms：How the Mycobiota and Fungal-Bacterial Interactions Impact Host Health and Disease [J]. Infect Immun，2021，89（4）：e00648-20.
[12] Beule L，Karlovsky P. Improved normalization of species count data in ecology by scaling with ranked subsampling （SRS）：application to microbial communities [J]. Peer J，2020，8：e9593.
[13] De Seta F，Lonnee-Hoffmann R，Campisciano G，et al. The Vaginal Microbiome：Ⅲ. The Vaginal Microbiome in Various Urogenital Disorders [J]. J Low Genit Tract Dis，2022， 26（1）：85-92.
[14] Rowan-Nash AD，Korry BJ，Mylonakis E，et al. Cross-Domain and Viral Interactions in the Microbiome [J]. Microbiol Mol Biol Rev，2019，83（1）：e00044-18.
[15] Drell T，Lillsaar T，Tummeleht L，et al. Characterization of the vaginal micro- and mycobiome in asymptomatic reproductive-age Estonian women [J]. PLoS One，2013，8（1）：e54379.
[16] Guo R，Zheng N，Lu H，et al. Increased diversity of fungal flora in the vagina of patients with recurrent vaginal candidiasis and allergic rhinitis [J]. Microb Ecol，2012，64（4）：918-927.
[17] Bradford LL，Ravel J. The vaginal mycobiome：A contemporary perspective on fungi in women’s health and diseases [J]. Virulence，2017，8（3）：342-351.
[18] Pérez JC. The interplay between gut bacteria and the yeast Candida albicans [J]. Gut Microbes，2021，13（1）：1979877.
[19] Li XV，Leonardi I，Iliev ID. Gut Mycobiota in Immunity and Inflammatory Disease [J]. Immunity，2019，50（6）：1365- 1379.
[20] Gutierrez MW，van Tilburg Bernardes E，Changirwa D，et al. “Molding” immunity-modulation of mucosal and systemic immunity by the intestinal mycobiome in health and disease [J]. Mucosal Immunol，2022，15（4）：573-583.
[21] Eichelberger KR，Cassat JE. Metabolic Adaptations During Staphylococcus aureus and Candida albicans Co-Infection [J]. Front Immunol，2021，12：797550.
[22] Jothi R，Hari Prasath N，Gowrishankar S，et al. Bacterial Quorum-Sensing Molecules as Promising Natural Inhibitors of Candida albicans Virulence Dimorphism：An In Silico and In Vitro Study [J]. Front Cell Infect Microbiol，2021，11：781790.
[23] Polke M，Leonhardt I，Kurzai O，et al. Farnesol signalling in Candida albicans - more than just communication [J]. Crit Rev Microbiol，2018，44（2）：230-243.
[24] Lee SC. mSphere of Influence：the Mycobiota in Human Health and Disease [J]. mSphere，2020，5（1）：e00974-19.
[25] Kruger W，Vielreicher S，Kapitan M，et al. Fungal-Bacterial Interactions in Health and Disease [J]. Pathogens，2019， 8（2）：70.
[26] Tortelli BA，Lewis WG，Allsworth JE，et al. Associations between the vaginal microbiome and Candida colonization in women of reproductive age [J]. Am J Obstet Gynecol，2020， 222（5）：471.e1-471.e9.
[27] Odds FC. Ecology and epidemiology of Candida species [J]. Zentralbl Bakteriol Mikrobiol Hyg A，1984，257：207-212.
[28] Chopra C，Bhushan I，Mehta M，et al. Vaginal microbiome：considerations for reproductive health [J]. Future Microbiol，2022，17：1501-1513.
[29] Tang L. Microbial interactions [J]. Nat Methods，2019，16（1）：19.
[30] Fan D，Coughlin LA，Neubauer MM，et al. Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization [J]. Nature Medicine，2015，21（7）：808-814.
[31] De Gregorio PR，Parolin C，Abruzzo A，et al. Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion [J]. Microb Cell Fact，2020，19（1）：133.
[32] Dube Y，Khan A，Marimani M，et al. Lactobacillus rhamnosus cell-free extract targets virulence and antifungal drug resistance in Candida albicans [J]. Can J Microbiol，2020， 66（12）：733-747.
[33] Vazquez-Munoz R，Dongari-Bagtzoglou A. Anticandidal Activities by Lactobacillus Species：An Update on Mechanisms of Action [J]. Front Oral Health，2021，2：689382.
[34] Plantinga TS，van Bergenhenegouwen J，Jacobs C，et al. Modulation of Toll-like receptor ligands and Candida albicans-induced cytokine responses by specific probiotics [J]. Cytokine，2012，59（1）：159-165.
[35] Kovács R，Majoros L. Fungal Quorum-Sensing Molecules：A Review of Their Antifungal Effect against Candida Biofilms [J]. J Fungi （Basel），2020，6（3）：99.
[36] Wang FJ，Liu ZH. Systematic analysis of protein expression in Candida albicans exposed to farnesol [J]. Chin Med J （Engl），2019，132（19）：2348-2353.
[37] Wang F，Liu Z，Zhang D，et al. In vitro activity of farnesol against vaginal Lactobacillus spp [J]. Eur J Obstet Gynecol Reprod Biol，2017，212：25-29.
[38] Bochenska O，Rapala-Kozik M，Wolak N，et al. Secreted aspartic peptidases of Candida albicans liberate bactericidal hemocidins from human hemoglobin [J]. Peptides，2013， 48：49-58.
[39] Tang C，Kamiya T，Liu Y，et al. Inhibition of Dectin-1 Signaling Ameliorates Colitis by Inducing Lactobacillus-Mediated Regulatory T Cell Expansion in the Intestine [J]. Cell Host Microbe，2015，18（2）：183-197.
[40] Kalia N，Singh J，Kaur M. Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections：a critical review [J]. Ann Clin Microbiol Antimicrob，2020，19（1）：5.
[41] Wang F，Xin C，Liu J，et al. Interactions between invasive fungi and symbiotic bacteria [J]. World J Microbiol Biotechnol，2020，36（9）：137.
[42] MacAlpine J，Robbins N，Cowen LE. Bacterial-fungal interactions and their impact on microbial pathogenesis [J]. Mol Ecol，2022. Online ahead of print.
[43] Merenstein D，Hu H，Wang C，et al. Colonization by Candida species of the oral and vaginal mucosa in HIV-infected and noninfected women [J]. AIDS Res Hum Retroviruses，2013，29（1）：30-34. |
|
|
|
